Bayer, Boehringer extend access to clinical trial data

Bayer and Boehringer Ingelheim outlined plans to increase access to their clinical trial data. Both are using to share clinical study reports and de-identified patient level-data with reseachers upon request. GlaxoSmithKline ($GSK), Novartis ($NVS), Roche ($RHHBY) and Sanofi ($SNY) also use the portal to manage data requests. Bayer release | Boehringer release